Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Marseille Cedex 9, France Clinical Trials

A listing of Marseille Cedex 9, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (8) clinical trials

Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

In recent years, considerable progress has been made in understanding the biology of chronic lymphocytic leukemia (CLL), resulting in the emergence of new therapeutic agents that have significantly improved the long-term survival of patients. However, LLC is still considered an incurable disease. Cytogenetic abnormalities are frequently found in this pathology. ...

Phase N/A

0.0 miles

Learn More »

Management of Paroxystic Atrial Fibrillation in French Intensive Care Units

Atrial fibrillation (AF) is a common arrhythmia in the ICU and is associated with significant morbidity. However, curative treatment remains unclearly established. In fact, there are no specific recommendations for new onset atrial fibrillation in ICU and only few studies have assessed this topic. The PAF-ICU trial is an observational, ...

Phase N/A

0.0 miles

Learn More »

Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma

The objective of this study research proposal is to model human gliomagenesis using 3-Dimensional (3D) brain organoids derived from human induced pluripotent stem cells (hiPSCs). The working hypothesis is that 3D brain organoids can develop glioma-like structures and recapitulate phenotypic traits of gliomas when generated from hiPSCs expressing genetic mutants ...

Phase N/A

0.0 miles

Learn More »

A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults

Infection with HIV-1 continues to be a serious health threat throughout the world. Chronic exposure to combination anti-retroviral therapy identified anti-retroviral associated long-term toxicities. Hence, there is a need to prevent these co-morbidities. GSK3640254 is a next-generation HIV-1 Maturation Inhibitor (MI) which may be effective for HIV-1 infection. This study ...

Phase

1.19 miles

Learn More »

Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease

Sickle cell disease is the most common genetic disease in the world. It results in the synthesis of an abnormal hemoglobin (HbS) which, in its deoxygenated form, polymerizes and causes structural changes in red blood cells (RBCs). They become more rigid and less deformable. The fragility of sickle-cell RBCs leads ...

Phase N/A

1.39 miles

Learn More »

PSYCHOLOGICAL CARE AND HYPNOSIS IN PATIENTS WITH CANCER

The general aim of the research that we propose to implement is to study the potential benefits of hypnosis in the psycho-social care of patients with cancer. The main goal of this study is to measure the effects of hypnosis sessions on quality of life, anxiety and patient adjustment strategies. ...

Phase N/A

1.39 miles

Learn More »

Circulating microRNAs and Degenerative Abdominal Aorta Aneurysm

Abdominal aortic aneurysm (AAA) is an aortic dilatation superior or equal to 30 mm with an estimated prevalence at 8% in men over 65 year-old. It evolves with no clinical signal until the rupture of the aortic wall with dramatic outcomes. The pathophysiological mechanisms include extracellular matrix remodeling, smooth muscle ...

Phase N/A

1.39 miles

Learn More »

Therapeutic Education for Harm Reduction in Patients With Alcohol Use Disorder

Alcohol is the most harmful psychoactive substance in terms of overall damage. Though abstinence remains the objective of most pharmacological and non-pharmacological approaches addressing alcohol use disorder, new therapeutic objectives of reduced alcohol intake and controlled-drinking have emerged. A standardized 10 weeks long, the "ChoiziTaConso" (CTC) therapeutic education program consisting ...

Phase N/A

4.59 miles

Learn More »